KLK7 overexpression promotes an aggressive phenotype and facilitates peritoneal dissemination in colorectal cancer cells
FEBS Open Bio · 2025
DOI: 10.1002/2211-5463.70171 ↗Kurz gefasst
Fachartikel in der Zeitschrift FEBS Open Bio, 2025. Verfasst von Yosr Z Haffani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Sorbonne Université, CNRS UMR8263-INSERM U1345, Institut de Biologie Paris Seine, France. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Kallikreins, Peritoneal Neoplasms. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wilhelm Sander-Stiftung, Ligue Contre le Cancer.
Abstract (Originalsprache)
Colorectal cancer (CRC) incidence and mortality continue to rise globally and new prognostic biomarkers are required for the development of targeted therapies. Several studies have suggested that tissue kallikrein‐related peptidases (KLKs), including KLK7, contribute to tumorigenesis. We previously demonstrated KLK7's tumor‐promoting role both in vitro and in vivo , but its role in CRC metastasis remains unclear. Here, using the Cancer Genome Atlas (TCGA), we confirmed that KLK7 expression is upregulated in advanced stages of CRC and its association with shorter progression‐free survival (PFS) of patients. To further understand the role of KLK7 in CRC metastasis, we assessed its expression in ascites from CRC patients with peritoneal metastasis (PM), investigated cell behavior following KLK7 overexpression, and examined its role in metastasis using a mouse model. High KLK7 levels were found in malignant ascites, but not in benign ascites. In xenograft models, KLK7‐overexpressing cells increased PM and exhibited higher Peritoneal Cancer Index (PCI) scores compared to controls. In vitro , KLK7 overexpression in HT29‐D4 human colon cancer cells significantly enhanced cell proliferation, colony formation, migration, spheroid formation, and adhesion to extracellular matrix proteins. Additionally, KLK7 overexpression altered cell morphology, upregulated moesin (MSN) and integrin subunits, suggesting cytoskeletal remodeling and matrix interactions. Taken together, these findings suggest that KLK7 is a driver of CRC progression and could serve as a potential prognostic marker for aggressive forms of CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sorbonne Université, CNRS UMR8263-INSERM U1345, Institut de Biologie Paris Seine, France.
- Laboratory of Physiopathology, Alimentation & Biomolecules PAB, LR17ES03, Higher Institute of Biotechnology-Sidi Thabet, University of Mannouba, Tunisia.
- Clinical Research Unit, Department of Obstetrics and Gynecology, Technische Universität München, Germany.
- National Cancer Institute Regina Elena (IRCCS), Rome, Italy.
- Department of Cellular and Molecular Medicine, The University of Arizona, Tucson, AZ, USA.
ORCID-Profile: Dalila Darmoul
Förderung
- Wilhelm Sander-Stiftung
- Ligue Contre le Cancer
Zitieren
APA
Haffani, Y. Z., Dreyer, T., Naim, M., Dico, R. L., Ignatenko, N. A., Magdolen, V., & Darmoul, D. (2025). KLK7 overexpression promotes an aggressive phenotype and facilitates peritoneal dissemination in colorectal cancer cells. FEBS Open Bio. https://doi.org/10.1002/2211-5463.70171
Vancouver
Haffani YZ, Dreyer T, Naim M, Dico RL, Ignatenko NA, Magdolen V, et al. KLK7 overexpression promotes an aggressive phenotype and facilitates peritoneal dissemination in colorectal cancer cells. FEBS Open Bio. 2025. doi:10.1002/2211-5463.70171
BibTeX
@article{Haffani2025,
author = {Haffani, Yosr Z and Dreyer, Tobias and Naim, Meriem and Dico, Rea Lo and Ignatenko, Natalia A and Magdolen, Viktor and Darmoul, Dalila},
title = {KLK7 overexpression promotes an aggressive phenotype and facilitates peritoneal dissemination in colorectal cancer cells},
journal = {FEBS Open Bio},
year = {2025},
doi = {10.1002/2211-5463.70171}
}
EUVIMED